Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-051715)

Filing Details

Accession Number:: 0001181431-12-051715
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-09-21 17:04:44
Reporting Period:: 2012-09-20

Filing Date:: 2012-09-21
Accepted Time:: 2012-09-21 16:04:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1108205	Curis Inc	CRIS	Biological Products, (No Disgnostic Substances) (2836)	043505116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1271411	Michael Gray	4 Maguire Road Lexington MA 02421	Coo And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-09-18	26,250	$1.09	112,863	No	4	M	Direct
Common Stock	Disposition	2012-09-18	26,250	$4.28	86,613	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Qualified stock option (right to buy)	Disposition	2012-09-18	26,250	$1.09	26,250	$1.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2006-09-25	2012-09-25	No	4	M	Direct

Footnotes

Options vested over a four-year period and became fully vested on September 25, 2006.
The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2012.
These shares were sold between $4.25-$4.31/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.